Vivos Therapeutics and South Palm Cardiovascular Associates Sign Definitive Agreements to Launch Regional Sleep Testing and Treatment Center

About Vivos Therapeutics, Inc.

Vivos Therapeutics, Inc. is a healthcare technology and medical care services organization focused on advancing and commercializing advanced diagnostic and treatment technology for patients suffering from breathing and sleep challenges arising from certain dentofacial irregularities like obstructive sleep apnea (OSA) and snoring in adults. Vivos' tools have been cleared by the U.S. Food and Drug Administration (FDA) for adult patients diagnosed with all levels of OSA and moderate-to-severe OSA in children ages 6 to 17. Vivos' groundbreaking Complete Airway Repositioning and Expansion (CARE) tools are the only FDA 510 cleared technology for managing serious OSA in adults, and the flagship DNA appliance is the first to receive clearance for managing moderate-to-severe OSA in children. OSA and insomnia affect a projected one billion adults aged 30-69 years worldwide, yet 80% or more remain undiagnosed and unaware of their condition. These long-term disorders are not just a sleep issue; they are closely connected to many severe chronic health conditions.

A recent report by Towards Healthcare highlights that the positive airway pressure devices market is growing, as CPAP is usually prescribed by primary care providers, nurse practitioners, internists, and neurologists for patients with obstructive sleep apnea. The benefits of initiating CPAP involve enhanced sleep quality, reduction or avoidance of snoring, and reduced daytime sleepiness. Most patients report improved concentration, memory, and cognitive function. Despite the significant advantages of CPAP therapy, compliance remains a significant challenge in both inpatient and outpatient settings. Patient compliance should be closely monitored, particularly during the initiation of management, to ensure long-term adherence. CPAP is usually prescribed by primary care providers, nurse practitioners, internists, and neurologists for individuals with obstructive sleep apnea.